Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | JAK2 | O60674 | 2/20 | 0.35 |
| ▸ | NTRK1 | P04629 | 2/20 | 0.35 |
| ▸ | MAPK14 | Q16539 | 10/20 | 0.34 |
| ▸ | CCNK | O75909 | 1/20 | 0.34 |
| ▸ | CDK12 | Q9NYV4 | 1/20 | 0.34 |
| ▸ | F2RL3 | Q96RI0 | 1/20 | 0.32 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3863406 | 0.96 | MAPK14 (0.37) | JAK2NTRK1MAPK14CCNKCDK12 | |
| SCHEMBL13646292 | 0.96 | MAPK14 (0.37) | JAK2NTRK1MAPK14CCNKCDK12 | |
| SCHEMBL3864307 | 0.84 | DGAT1 (0.42) | MAPK14DGAT1 | |
| SCHEMBL30855733 | 0.68 | DGAT1 (0.39) | DGAT1 | |
| SCHEMBL31411454 | 0.66 | DGAT1 (0.38) | DGAT1 | |
| SCHEMBL31411444 | 0.65 | DGAT1 (0.36) | DGAT1 | |
| SCHEMBL25366051 | 0.64 | DGAT1 (0.45) | DGAT1 | |
| SCHEMBL29493833 | 0.64 | DGAT1 (0.45) | DGAT1 | |
| SCHEMBL15906056 | 0.64 | MAPK14 (0.47) | JAK2NTRK1MAPK14 | |
| SCHEMBL4014501 | 0.63 | BRD4 (0.38) | MAPK14DGAT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1919913-A2 | P38 MAP KINASE INHIBITORS AND METHODS FOR USING THE SAME | F.HOFFMANN-LA ROCHE AG (CH) | 2008-05-14 | — | — | EP | disclosed |
| WO-2007023110-A2 | P38 MAP KINASE INHIBITORS AND METHODS FOR USING THE SAME | F. HOFFMANN-LA ROCHE AG (CH) | 2007-03-01 | — | — | WO | disclosed |